Zeltia and PharmaMar

27.10.2005 – 09:28
Zeltia and PharmaMar: R&D Spend Increases by 10% in the 9 Months to September 2005
Madrid (ots/PRNewswire) - Zeltia S.A. (ZEL SM; ZEL.MC), Spanish pioneer and leader in biotechnology, announces 9 months results to September 2005. Research and Development spend amounted to EUR31 million during this period, a 10% increase year on year. 83% of this amount was accounted for by PharmaMar. Notable advances at PharmaMar in the last quarter include ...
mehr
21.06.2005 – 19:12
Zeltia to Raise New Funds Through Institutional Placing
Madrid, Spain (ots/PRNewswire) - Zeltia S.A, the Spanish consumer chemicals and biotechnology group announces today that its Board of Directors has authorized a capital increase through a private placement with qualified international institutional investors. The capital increase is expected to raise approximately one hundred (100) million euros. A "green shoe" of up to 15% of the amount raised can be exercised by ...
mehr